The World Health Organization (WHO) today listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen(Johnson & Johnson), for emergency use in all countries and for COVAX roll-out.
More
Easy to manufacture and update, these new vaccines may be a powerful tool against emerging variants and other infectious diseases
More
The emergence of new coronavirus variants has raised major questions around whether currently available vaccines will be effective against them, the head of the World Health Organization (WHO) said on Monday.
More
To speed up access to COVID-19 vaccinations in the developing world, on the eve of the new year, the UN health agency approved Pfizer and BioNTech’s vaccines for emergency use.
More
Reports about the release of COVID-19 vaccines by the end of the year are promising, but plans for distribution are still being worked out.
More
Addressing the financing gap to provide COVID-19 vaccines for everyone, everywhere, is an urgent priority, World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus said on Friday, in an appeal for stepped-up funding to support poorer countries.
More
EMA Executive Director Emer Cooke will update MEPs on the latest developments concerning the authorisation of vaccines against COVID-19, on Thursday at 14.00.
More